TCBPY — TC Biopharm (Holdings) Share News
0.000.00%
Last trade - 00:00Brief: TC Biopharm Announces Pricing Of $3.5 Million Public Offering
Brief: TC Biopharm Begins Dosing Phase 2B Clinical Study Evaluating Its Lead Compound, Omnimmune®
Brief: TC Biopharm Announces Key Additions To Scientific Advisory Board
TC Biopharm rises on cancer therapeutic's shelf life approval in UK
Brief: TC BioPharm Receives MHRA Approval For 18-Month Extrapolated Shelf-Life Of Allogeneic Cell Therapy Product, Omnimmune
Brief: TC Biopharm Ltd Announces Pricing Of $4 Mln Underwritten Public Offering
Brief: TC BioPharm (Holdings) PLC Files Amended Prospectus Related To Offering Of 4.3 Million ADSS
Brief: TC BioPharm Files For Public Offering Of 6.96 Million ADS
Brief: TC BioPharm Announces Formation of Scientific Advisory Board
Brief: TC Biopharm Receives MHRA And Research Ethics Committee Approvals To Initiate Phase 2B/3 Clinical Trials For Treatment Of Acute Myeloid Leukemia
Brief: TC Biopharm Announces FDA Orphan Drug Status Granted For Omnimmune®
Brief: TC Biopharm Announces Positive Phase 1B/2A Data In Late-Stage Acute Myeloid Leukemia Patients
Brief: TC Biopharm Announces Appointment Of New Board Members
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
Brief: TC Biopharm Announces Pricing Of Upsized $17.5 Mln IPO And Nasdaq Listing
Brief: TC Biopharm Holdings Offering An Aggregate Of 3.8 Million ADS And 7.5 Million Warrants
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM